Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (5949)	11/13/1998 10:23:00 AM
From: N/E PATSFAN	Respond to of 9719

[ GZTC ] Thanks Rick ... I didn't play this one as the pre-opening didn't look to exciting but I'll check out BTRN and consider it highly for my L-T portfolio. Thanks for the info ... NEPF

To: scaram(o)uche who wrote (5949)	11/15/1998 5:15:00 AM
From: Rocketman	Read Replies (2) \| Respond to of 9719

From CBS MarketWatch: cbs.marketwatch.com <<<<<<<<<< Biotech stocks worth a look? CHICAGO -- More breakthrough products, a speedier Food and Drug Administration approval process, dramatic recent stock price gains and a trend toward consolidation. These factors are improving the image of the biotechnology stock, long considered a pariah by a stock market that tends in uncertain times to value dependability and solid earnings over hopes, dreams and red ink. Stock pickers have mentioned such companies as Agouron (AGPH), Chiron (CHIR), Isis (ISIP), Imclone Systems (IMCL), AxyS (AXPH), Xoma (XOMA), Amgen (AMGN), Biogen (BGEN) and others as worth some exploration. (Chicago Tribune) >>>>>>>>>>